Finding 1137575 (2023-005)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2025-05-20

AI Summary

  • Core Issue: Two timesheets lacked supervisor signatures and did not fully capture all hours worked.
  • Impacted Requirements: PHIMC's policy and 2 CFR 200.430 require accurate, reviewed, and approved timecards.
  • Recommended Follow-Up: PHIMC should reinforce the time reporting policy to ensure all timesheets are properly completed and reviewed.

Finding Text

Agencies: Corporation for National Community Service and U.S. Department of Health and Human Services Federal Program: All federal awards. Criteria: It is PHIMC's policy to have timecards prepared and signed by the employee and their applicable supervisor. In addition, 2 CFR 200.430 (i) Compensation-Personnel Services, Standards for Documentation of Personnel Services requires payroll systems must be based on records that accurately reflect the work performed and supported by a system of internal controls that provides reasonable assurances that charges are accurate; allowable and reasonable; and properly allocated. Condition: We identified an instance in which a timesheet was not signed off by applicable supervisor and there was no evidence of review. In addition, we noted an instance in which the timesheet did not include all time worked. Context: Out of a sample of 40 timesheets, two timesheets were not complete. Sample was not statistically valid. Cause: The lack of supervisory authorizations and incomplete timesheets appear to be a result of human error and an oversight. Questions Costs: No questioned costs were identified. Effect: Amounts charged to federal awards related to these incomplete timesheets were accurate. However, lack of supervisory review and inaccurate timesheet data can lead to errors in payroll and government grant record keeping. Recommendation: We recommend PHIMC reiterate applicable policy, and ensure all timesheets are prepared, reviewed, and contain appropriate approvals. Views of Responsible Officials: Management plans to reiterate the time and effort reporting policy and ensure timesheets are completed in accordance with PHIMC policy

Categories

Internal Control / Segregation of Duties Allowable Costs / Cost Principles Reporting

Other Findings in this Audit

  • 561096 2023-002
    Significant Deficiency
  • 561097 2023-004
    Significant Deficiency
  • 561098 2023-005
    Significant Deficiency
  • 561099 2023-002
    Significant Deficiency
  • 561100 2023-004
    Significant Deficiency
  • 561101 2023-005
    Significant Deficiency
  • 561102 2023-002
    Significant Deficiency
  • 561103 2023-004
    Significant Deficiency
  • 561104 2023-005
    Significant Deficiency
  • 561105 2023-002
    Significant Deficiency
  • 561106 2023-004
    Significant Deficiency
  • 561107 2023-005
    Significant Deficiency
  • 561108 2023-006
    Significant Deficiency
  • 561109 2023-007
    Significant Deficiency
  • 561110 2023-002
    Significant Deficiency
  • 561111 2023-004
    Significant Deficiency
  • 561112 2023-005
    Significant Deficiency
  • 561113 2023-006
    Significant Deficiency
  • 561114 2023-007
    Significant Deficiency
  • 561115 2023-002
    Significant Deficiency
  • 561116 2023-004
    Significant Deficiency
  • 561117 2023-005
    Significant Deficiency
  • 561118 2023-006
    Significant Deficiency
  • 561119 2023-007
    Significant Deficiency
  • 561120 2023-002
    Significant Deficiency
  • 561121 2023-004
    Significant Deficiency
  • 561122 2023-005
    Significant Deficiency
  • 561123 2023-006
    Significant Deficiency
  • 561124 2023-007
    Significant Deficiency
  • 561125 2023-002
    Significant Deficiency
  • 561126 2023-004
    Significant Deficiency
  • 561127 2023-005
    Significant Deficiency
  • 561128 2023-002
    Significant Deficiency
  • 561129 2023-004
    Significant Deficiency
  • 561130 2023-005
    Significant Deficiency
  • 561131 2023-002
    Significant Deficiency
  • 561132 2023-004
    Significant Deficiency
  • 561133 2023-005
    Significant Deficiency
  • 1137538 2023-002
    Significant Deficiency
  • 1137539 2023-004
    Significant Deficiency
  • 1137540 2023-005
    Significant Deficiency
  • 1137541 2023-002
    Significant Deficiency
  • 1137542 2023-004
    Significant Deficiency
  • 1137543 2023-005
    Significant Deficiency
  • 1137544 2023-002
    Significant Deficiency
  • 1137545 2023-004
    Significant Deficiency
  • 1137546 2023-005
    Significant Deficiency
  • 1137547 2023-002
    Significant Deficiency
  • 1137548 2023-004
    Significant Deficiency
  • 1137549 2023-005
    Significant Deficiency
  • 1137550 2023-006
    Significant Deficiency
  • 1137551 2023-007
    Significant Deficiency
  • 1137552 2023-002
    Significant Deficiency
  • 1137553 2023-004
    Significant Deficiency
  • 1137554 2023-005
    Significant Deficiency
  • 1137555 2023-006
    Significant Deficiency
  • 1137556 2023-007
    Significant Deficiency
  • 1137557 2023-002
    Significant Deficiency
  • 1137558 2023-004
    Significant Deficiency
  • 1137559 2023-005
    Significant Deficiency
  • 1137560 2023-006
    Significant Deficiency
  • 1137561 2023-007
    Significant Deficiency
  • 1137562 2023-002
    Significant Deficiency
  • 1137563 2023-004
    Significant Deficiency
  • 1137564 2023-005
    Significant Deficiency
  • 1137565 2023-006
    Significant Deficiency
  • 1137566 2023-007
    Significant Deficiency
  • 1137567 2023-002
    Significant Deficiency
  • 1137568 2023-004
    Significant Deficiency
  • 1137569 2023-005
    Significant Deficiency
  • 1137570 2023-002
    Significant Deficiency
  • 1137571 2023-004
    Significant Deficiency
  • 1137572 2023-005
    Significant Deficiency
  • 1137573 2023-002
    Significant Deficiency
  • 1137574 2023-004
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.940 Hiv Prevention Activities Health Department Based $155,102
93.959 Block Grants for Prevention and Treatment of Substance Abuse $145,670
93.145 Aids Education and Training Centers $105,890
94.006 Americorps State and National 94.006 $8,945